TrialsgrambetaRCTs are beautiful

REDUCE-IT

2019

Reduction of Cardiovascular Events with Icosapent Ethyl

In 8,179 statin-treated patients with high triglycerides, icosapent ethyl reduced major adverse cardiovascular events compared with placebo.

Result

Efficacy: CV death, MI, stroke, revascularisation or unstable anginaHR 0.75

Below 1 favours icosapent ethyl, above 1 favours placebo.

Event rates
Absolute difference
4.8 points

The absolute difference is derived from the event rates.

Original publication
Subtopic
Triglycerides
Design
Double-blind RCT
Relevance
Important: one of several pillars.
Source
Bhatt DL, et al. N Engl J Med. 2019;380(1):11-22.doi 10.1056/NEJMoa1812792

Discussion & critique

The mineral-oil placebo raised LDL and CRP, so the true effect is probably smaller than the 25 % reduction. STRENGTH, with a different omega-3, was negative.

Discussed in podcasts